INTRODUCTION
Urban American Indians and Alaska Natives (AI/ANs) are more likely to obtain substance abuse treatment than are other city residents. For example, analyses of the 2013 National Survey on Drug Use and Health showed that 2.3% of urban AI/ANs used specialty substance abuse treatment in the year prior to survey, versus 0.9% of non-Natives. Moreover, 1.4% of urban AI/AN survey respondents reported using residential substance abuse treatment in the previous year versus only 0.4% of non-Natives.
Unfortunately, resources are markedly limited for urban AI/AN substance abuse treatment (Legha & Novins; Wright et al., 2011) . Indeed, Roubideaux (2002) discussed "the severe levels of under-funding and lack of resources in the Indian health system and the need for more funding for Indian health care" (p. 1403) while Lillie-Blanton and Roubideaux (2005) noted that "large disparities exist in the funding and availability of health services for AIAN people relative to other Americans" (p. 759). Moreover, as Roubideaux (2002) pointed out, "lack of adequate funding and services is a constant stress on the Indian health system" (p. 1402). Focusing on city dwellers, Castor et al. (2006) reported that "although UIHOs [Urban Indian Health Organizations] are the primary health care venue for urban American Indians/Alaska Natives, who represent more than 60% of the nationwide AI/AN population, IHS [Indian Health Service] allocations for these organizations represent 1% of the total IHS budget" (p. 1484).
These resource constraints are especially pertinent for residential substance abuse treatment programs, which have notably higher costs than outpatient services (French, Popovici, & Tapsell, 2008) . To our knowledge, no data are available about the costs of residential substance abuse care for urban AI/ANs. Although Saylors (2003) described services provided to AI/AN clients of residential programs in Oakland and San Francisco and Wright et al. (2011) discussed services (especially traditional healing programs) for outpatient and residential clients of an agency in Oakland that focuses on AI/ANs, costs were not addressed. It is worth noting that this situation is in marked contrast to the extensive literature on costs of general population residential substance abuse treatment programs (Alexandre et al., 2012; French, Dunlap, Zarkin, McGeary, & McLellan, 1997; French, Salome, Sindelar, & McLellan, 2002; French et al., 2008; Roebuck, French, & McLellan, 2003) .
The lack of cost information is especially noteworthy because economic data are needed by policymakers and funders who must decide on provision and financing of treatment programs (French et al., 1997; French & Drummond, 2005) for the rapidly growing urban AI/AN population. Moreover, substance abuse treatment program managers and developers need cost data in order to construct sustainable service packages for urban AI/ANs.
In particular, data comparing costs for residential programs focused on urban AI/ANs versus costs for mainstream (general population) residential treatment services would be useful.
It could well be imagined that programs with culturally specific services are more costly than conventional care. Indeed, programs that have been described (e.g., Wright et al., 2011) often provide services specific to AI/ANs (such as sweat lodges) that are complements to (rather than substitutes for) conventional substance abuse treatments. The implication is that the more extensive AI/AN programs would have higher costs than mainstream services. However, there have been few (if any) comparisons of costs between agencies focusing on AI/ANs and mainstream treatment programs.
In addition, AI/AN clients of urban residential programs may have more severe substance abuse-related problems than their non-Native counterparts. For example, the 2012 Treatment Episode Data Set (described below) showed that first substance use was under the age of 12 years for 12% of AI/ANs admitted to urban residential treatment agencies, versus only 7% for non-Natives. And only 7% of AI/AN admissions were for employed clients, versus 9% for nonNatives. Both factors are associated with increased severity of substance abuse (McCamant, Zani, McFarland, & Gabriel, 2007) . Indeed, previous research shows that severity indicators, such as length of substance abuse, are powerful predictors of treatment outcomes (Caspi, Turner, Panas, McCarty, & Gastfriend, 2001; Chong & Lopez, 2007; McCamant et al., 2007) . For example, Chong and Lopez (2007) found that, for AI women in Arizona, the number of prior alcohol treatment episodes was highly predictive of relapse to drinking 6 months after completing the index (current) urban residential treatment program. Specifically, each prior alcohol treatment episode increased the odds of relapse by 90%. Therefore, it is reasonable to hypothesize that greater severity of clients' substance abuse would translate into higher costs for AI/AN programs versus mainstream care.
For these reasons, we undertook this project to a) examine costs of service provision at residential substance abuse treatment programs designed for urban AI/ANs and b) compare the study facilities with information from general population programs. The hypothesis to be tested was that the culturally specific programs would be more costly than analogous mainstream treatments.
METHODS
Agencies to be studied were selected based on the following criteria: a) chiefly serving urban AI/ANs, b) providing residential substance abuse treatment, and c) offering short-term and/or long-term residential programs. In this context, "urban" refers to metropolitan areas (also known as Core Based Statistical Areas; i.e., cities) as defined by the U.S. Census Bureau.
Residential substance abuse treatment, as defined by the Substance Abuse and Mental Health Services Administration (SAMHSA, 2007) , is a nonhospital, nondetoxification rehabilitation program whose clients stay overnight at the facility. Short-term programs typically have 30-day (or less) planned lengths of stay, according to SAMHSA, whereas long-term programs have planned lengths of stay greater than 30 days. The study years were chosen to include 2006 so that cost data could be compared with national figures provided by French et al. (2008) . Given research resource constraints, the sample was limited to two study agencies (denoted Agency A and Agency B). A companion paper describes the study agencies in detail ("Residential substance abuse treatment for urban American Indians and Alaska Natives Part I: Services and staff," in this issue).
Both programs are private, not-for-profit agencies funded by numerous entities including IHS and Medicaid. The two programs maintained their own financial data and reported service utilization to their respective state substance abuse agencies. Both study agencies utilized Microsoft Excel software for financial records and both had annual independent audits of finances. The agencies were also similar in that they owned their residential treatment program properties and equipment. Thus, neither agency had facility lease or rent expenditures. Fiscal years for the two agencies were the same (July 1 through June 30).
Procedures
The project began with extensive discussions between agency staff (including senior leaders) and members of the research team, leading to agreement on the study protocol. In addition, the meetings served to introduce the project to agency staff members. Each agency hired a masters-level AI/AN researcher who facilitated data acquisition. In addition, the directors of the two agencies served as consultants to the project.
All interviews, data collection, data entry, and preliminary data management pertaining to costs were conducted by a doctoral level AI researcher. Cost information was obtained with the Brief Drug Abuse Treatment Cost Analysis Program (Brief DATCAP), which is described subsequently. Data sources included Microsoft Excel spreadsheets for financial records, annual audits, category-specific Excel spreadsheets, and face-to-face and telephone interviews, as well as email correspondence to transmit and clarify data from each agency. Data were obtained for three consecutive fiscal years (2005-2006, 2006-2007, and 2007-2008) .
Following protocols developed by French et al. (2002) and described in the DATCAP User's Manual (French, 2002) , a letter of introduction to the project and a copy of the instrument were provided to each agency. At subsequent meetings, the financial officer and the treatment program director of each agency reviewed data needs, sources, and mechanisms for data retrieval and sharing. Neither agency received remuneration for staff time, although both agencies received gift cards and a copy of their data for program use.
It should be noted that the two agencies had similar but not identical accounting procedures. For example, Agency A included labor costs for mental health staff in the residential program budget. Conversely, mental health services for Agency B clients were provided as part of the outpatient program.
Measures Brief Drug Abuse Treatment Cost Analysis Program (DATCAP)
Cost data were obtained via the Brief DATCAP, which is a public domain instrument (Alexandre et al., 2012; French, 2002; French et al., 1997; French et al., 2008; French, Roebuck, & McLellan, 2004; French et al., 2002) available online that is widely used to ascertain costs of substance abuse treatment. The DATCAP approach to program costs involves collecting data on numbers of clients, program personnel, contracted services, buildings and facilities, equipment, supplies and materials, and miscellaneous resources consumed (mortgage and interest, property taxes, insurance, maintenance, and utilities are included here). DATCAP generates both accounting costs and economic (also known as opportunity) costs for substance abuse treatment programs.
National Comparison Data
National data sets were used to provide comparisons. For convenience, agencies in the national data sets will be referred to as "mainstream" programs. This information was accessed online via the Substance Abuse and Mental Health Data Archive, then at the Inter-University Consortium for Political and Social Research maintained by the University of Michigan. For the national data sets, "urban" admissions, discharges, and agencies, respectively, were defined as those within Core Based Statistical Areas (i.e., cities).
The SAMHSA-supported Treatment Episode Data Set (TEDS) compiles information about admissions to and discharges from virtually all publicly funded substance abuse treatment programs in the United States (Albrecht, Lindsay, & Terplan, 2011; Mutter, Ali, Smith, & Strashny, 2015; Stahler, Mennis, & DuCette, 2016; Terplan, Smith, Kozloski, & Pollack, 2010) .
The unit of analysis is generally the admission (or the discharge), so that a given person may be represented more than once. Data from 2006 were examined pertaining to discharges of AI/ANs from residential rehabilitation programs located in Core Based Statistical Areas. There were 2,075 discharges from short-term programs and 2,668 discharges from long-term programs. The nationwide ADSS cost study was used in conjunction with data from French et al. (2008) to estimate economic costs of 48 nationally representative residential treatment programs that were comparable to the two study agencies. The project computed accounting costs in 1996 dollars (SAMHSA, 2003) . Note that accounting costs are similar to but not the same as economic costs (Woodward et al., 2008 ).
The ADSS accounting costs per client per day varied with the average daily census. As expected (French et al., 2008; Woodward et al., 2008) comparisons between study agency costs and national data needed to address program size. Therefore, the ADSS accounting cost data were employed to adjust for program size via the following approaches.
In the first step, the ADSS daily accounting costs were converted into weekly economic costs. Detailed data on weekly economic costs were obtained (French, personal communication, October 13, 2013) for 21 adult residential treatment programs studied by French et al. (2008) .
Percentiles were computed for the weekly economic costs of the 21 adult residential programs (French et al., 2008) . Next, percentiles of daily accounting costs were computed for the 48 residential programs in the ADSS cost study using facility weights and addressing the complex sampling design. The weekly economic cost percentiles from French et al. (2008) were linked with the closest 21 ADSS daily accounting cost percentiles. The logarithms of weekly economic costs (French et al., 2008) were regressed on the logarithms of ADSS daily accounting costs via which had R 2 of 0.285 and standard error of estimate of 0.292. Heteroscedasticity was excluded via visual examination as per Rosopa, Schaffer, and Schroeder (2013) and via the test described by Breusch and Pagan (1979) , which was not statistically significant.
The third step was to predict the expected mean weekly economic costs for the study agencies based on the two programs' average daily census figures. Assuming a Gaussian distribution, the expected first and third quartiles were computed as the predicted mean minus or plus (respectively) the standard error of estimate times 0.675. These estimates were then exponentiated to yield predicted means and quartiles for the weekly economic costs (in 2006 dollars).
The project was approved and overseen by the Oregon Health & Science University
Institutional Review Board. Data analysis used SPSS version 20.
RESULTS

Study Agency Compared to National Demographics
State substance abuse agency data in the two right columns of Table 1 showed that the study agencies overall (outpatient plus residential) had roughly 600 to 800 admissions annually.
Study Agency A served mainly AI/AN clients (68%), whereas approximately half of Agency B clients (45%) were AI/AN. Most clients at the study agencies obtained residential services.
The study agency AI/AN residential clients were mostly unemployed, never married, working-age adults. There was a slight majority of women among Agency A residential AI/AN clients, whereas women residential AI/AN clients were outnumbered by men at Agency B. Most of the study agencies' AI/AN residential clients (70% to 85%) had been arrested at some time.
Alcohol was the primary substance of abuse for most of the AI/AN residential clients, whereas injection drug use was uncommon. Most of the AI/AN residential clients completed treatment, and most were described as abstinent at discharge.
Outpatient AI/ANs at the study agencies were mostly male, unemployed, working-age adults, some 60% of whom had been arrested at some time. Again, alcohol was the primary substance for AI/AN outpatient clients, and injection drug use was uncommon. On the other hand, it was rare for AI/AN outpatients to complete treatment, and abstinence at discharge from outpatient care was infrequent. Table 1 also shows national substance abuse treatment data for non-Natives and AI/ANs, respectively. In contrast to the study agencies, most nationwide admissions were to outpatient programs. Most national residential admissions were for working age, never married, unemployed males. Nationwide employment rates for both non-Native and AI/AN admissions exceeded those for study agency clients. Nationally, alcohol was the primary substance for most AI/AN residential admissions (56%), but only for 40% of non-Native residential admissions.
Needle use was uncommon. Regarding outpatients, study agency client demographics were similar to those for nationwide admissions except that employment rates were lower for study agency clients than for their national counterparts.
Staff data are also given in Table 1 . The study agencies (right columns) had more counselors than the national average (left column). Most counselors at Agency A were AI/AN, but not at Agency B. 
Agency A Residential Funding
Funding for residential treatment at Agency A is provided through grants from the state addictions and mental health program, IHS, state and local criminal justice agencies, an agreement with a county family involvement program, Medicaid, private payers (including tribes), and private insurance. All of the billing is handled through Agency A's financial services department. The client's funding source does not influence the treatment approach for that client.
Agency B Residential Funding
At Agency B, direct care services are provided on a sliding-fee basis. Many public and private insurance programs are accepted. Additional funding is received from public and private sources, including federal, state, and local government as well as Medicaid and Medicare.
Agency B contracts with IHS under Title V of the Indian Health Care Improvement Act (P. L.
94-437).
Several The residential program at Agency B also receives drug court referrals from IHS. In addition, there are clients funded by direct payments from tribes. There are no differences in services provided based on the client's funding source. Table 2 shows the accounting costs for the residential programs. Not surprisingly, labor is by far the largest cost category. Over the study years, labor represented 76% of the accounting costs at Agency A and 56% at Agency B. Supplies (such as food) represented the next largest cost category overall. Supplies comprised approximately one tenth of costs at Agency A but one fifth at Agency B.
Residential Accounting Costs at the Study Agencies
Crude comparisons can be made with residential data from ADSS, which used somewhat different cost definitions. In the national ADSS study, personnel comprised 63% of total costs for 48 nonhospital residential programs (left column of Table 2 ). 
Study Agency and National Administrative Data
Costs need to be interpreted in view of agency size. As shown in Table 3 Table 3 ). With 62 licensed beds, Agency A was at the 88th percentile nationally, while Agency B (with 96 beds) was at the 95th percentile. Thus, both study agencies were much larger than the typical urban residential treatment program with respect to bed counts. Table 3 also shows average daily census for the two study agencies. Agency A had, on average, approximately 45 clients in residence, whereas Agency B typically had 85 clients. A complication here is that the administrative data for Agency A (such as the average daily census) pertain only to designated (i.e., adult) clients. In other words, the data do not reflect clients' children staying at the Agency A residential program.
Nationwide, the average number of urban residential clients (on the survey date) was 30 (far left column of Table 3 ). Agency A with, on average, 45 clients was at the 87th percentile for long-term (90-day) urban residential programs. Agency B (with an average of 85 clients) was at the 99th percentile for short-term urban residential agencies. Looking at all urban residential agencies (both short-and long-term) nationwide, Agency B was at the 94th percentile.
Lengths of stay are also presented in Table 3 . The Agency A average length of stay (10-12 weeks) corresponds to the long-term nature of its residential program. Analogously, the 5-week average length of stay at Agency B reflects the short-term residential treatment provided to most of its clients. (It should be mentioned that some Agency B clients undertook long-term care after completing short-term residential treatment.) As expected, then, Agency A residential clients had lengths of stay approximately twice that of Agency B clients. National TEDS discharge data for 2006 showed that urban short-term residential AI/AN clients had an average length of stay of 29 days, or 4 weeks (far left column of Table 3 ). Urban AI/ANs discharged from long-term residential programs had an average length of stay of 71 days, or 10 weeks. Thus, the study agencies had lengths of stay slightly longer than expected based on national data. Table 3 shows that Agency A had approximately 80 to 100 residential admissions annually. Inconveniently, the residential admissions data for Agency B are complicated by inclusion of "re-admissions." One approach to these data is to generate estimates based on the formula "admissions equal census divided by length of stay." These estimates suggest that Agency B had approximately 200 to 300 annual residential admissions. Using this estimate, Agency A had fewer annual admissions than Agency B.
Nationwide data from NSSATS (left column of Table 3) indicated that, for urban programs providing residential treatment, the average number of admissions in 2006 was 346.
However, this nationwide figure combines short-and long-term residential programs and may include admissions to outpatient services (for some agencies in the national survey). As best as can be determined, it appears that the study agencies had somewhat fewer annual admissions than did the average mainstream program. 
Economic Costs for the Study Agencies
Using the administrative data, accounting costs were translated into the economic costs shown in Table 3 . Whereas Agency A had weekly economic costs of approximately $850 per client, the corresponding weekly figure for Agency B was $550 per client. The treatment episode costs were approximately $9,000 for Agency A and $2,500 for Agency B.
These figures for the study agencies can be compared to the national "cost bands"
provided by French et al. (2008) and shown in the left column of Table 3 . For adult residential services, French et al. (2008) studied some 22 programs, which had an average length of stay of 13 weeks, with a median length of stay of 11 weeks.
In the national data, the inter-quartile range (cost band) for weekly economic cost per client ranged from $607 to $919 in 2006 U.S. dollars (French et al., 2008) . The treatment episode cost band ranged from $2,907 to $11,260 in 2006 U.S. dollars.
Thus, the weekly economic costs for Agency A were well within the cost band based on national data. Similarly, the treatment episode costs for Agency A were as expected based on the studies by French et al. (2008) . Conversely, Agency B had weekly costs notably below the cost band reported by French et al. (2008) and also had treatment episode costs lower than expected based on the national data.
Taking into account program size, the predicted mean weekly economic cost for Agency A was $521, with a predicted third quartile cost of $772. Over the study years, the observed weekly economic cost ($850) for Agency A corresponded to a predicted 84th percentile. In other words, Agency A costs were toward the upper end of the predicted range, taking into account the average daily census. Conversely, for Agency B, the predicted mean weekly economic cost was $548, which was essentially equal to the observed figure ($550).
CONCLUSIONS
Contrary to the hypothesis, the study programs had costs similar to or lower than those for mainstream facilities. Whether measured per week or per treatment episode, one study agency had costs well within national cost bands, while the other study agency's costs were notably below the national figures.
One explanation for the low costs may be that the study agencies operated in environments with markedly limited financial resources. In an editorial, Roubideaux (2002) summarized the situation by saying "We also must help educate others, especially our country's leaders, on the severe levels of under-funding and lack of resources in the Indian health system and the need for more funding for Indian health care" (p. 1403). Conceivably, the study agencies may have used funds more efficiently than did mainstream programs with greater financial resources. Indeed, greater efficiency is also suggested by the finding that study agency clients had greater severity (shown, for example, by their unemployment levels) than did their national
counterparts.
An additional explanation could be economies of scale. Namely, the study agencies were notably larger than the typical urban residential substance abuse treatment program. For example, the study agencies exceeded roughly 90% of urban residential programs with respect to numbers of beds and clients. French et al. (2008) and Woodward et al. (2008) pointed out that powerful determinants of costs include economies of scale as well as lengths of stay. Indeed, when adjustments were made to account for program size, the costs observed at the study agencies appeared close to those predicted from national data.
Staff mixtures may also explain costs. For example, one study agency made considerable use of residential aides rather than certified substance abuse treatment counselors (see "Residential substance abuse treatment for urban American Indians and Alaska Natives Part I:
Services and staff," in this issue). And both study agencies exceeded national averages with regard to numbers of clients per full-time substance abuse treatment counselor. Therefore, some cost savings may be due to staff composition. On the other hand, the project was limited to two urban AI/AN treatment programs. The study agencies may or may not be representative of other facilities focused on this population.
However, demographics of the study agency clients were generally similar to those of their national counterparts, except that study clients were less likely to be employed. Also, as described in the companion paper ("Residential substance abuse treatment for urban American Indians and Alaska Natives Part I: Services and staff," in this issue), the study programs illustrate notable variations in the types of services provided.
By design, the present report focused on costs. Thus, client data (including treatment outcomes) are not provided here (but will be described elsewhere). However, it should be noted These limitations notwithstanding, the present project showed that urban AI/ANs who have substance abuse problems can be served by residential treatment programs with modest budgets.
This result is noteworthy because the study agencies provide numerous culturally specific as well as mainstream services ("Residential substance abuse treatment for urban American Indians and Alaska Natives Part I: Services and staff," in this issue). In the words of Lillie-Blanton and Roubideaux (2005) , this finding addresses "an important but often overlooked public policy issue-how to more effectively address the health care needs of this nation's first citizens" (p.
759). Indeed, these results are especially pertinent for substance abuse treatment program developers and managers who recognize that "efforts to improve health care for American Indians and Alaska Natives need to be more culturally appropriate and community based and must help build community capacity" (Lillie-Blanton & Roubideaux, 2005, p. 760 
